Paliperidone
Invega, Paliperidone Janssen, Paliperidone Janssen-Cilag International, Trevicta, Xeplion (paliperidone) is a small molecule pharmaceutical. Paliperidone was first approved as Invega on 2006-12-19. It is used to treat bipolar disorder, depressive disorder, schizophrenia, and schizophrenia spectrum and other psychotic disorders in the USA. It has been approved in Europe to treat psychotic disorders and schizophrenia.
| Trade Name | Invega, Paliperidone Janssen, Paliperidone Janssen-Cilag International, Trevicta, Xeplion |
|---|---|
| Common Name | Paliperidone |
| Indication | bipolar disorder, depressive disorder, psychotic disorders, schizophrenia, schizophrenia spectrum and other psychotic disorders |
| Drug Class | Antipsychotics (risperidone type) |
